April 2, 2014, Montréal, Canada – As part of Vantage BioTrials’ continued focus and dedication in providing superior clinical trial management services to the pharmaceutical industry, we are excited to launch and share with our Sponsors, industry professionals and employees our own White Paper.

As part of our commitment, Vantage BioTrials’ White Paper will serve to share as an informational resource to give our readers a more detailed look at specific areas of the pharmaceutical/clinical research industry, in addition to providing our own insight and knowledge regarding certain topics, guidelines, practices and policies.

As a result, we are excited to present our first issue in the area of Medical Device entitled “Class II-IV Medical Device Investigational Testing in Canada”. Vantage BioTrials has been a growing leader in the Medical Device arena having performed numerous clinical trials, some of which have successfully received 510(k) clearances by the Food & Drug Administration (FDA).

Vantage BioTrials would like to especially thank all its Sponsors, partners and employees for their continued support, loyalty and trust that they have instilled in us over the years.

To view the file please click on the following link:  Vantage BioTrials_White_Paper_Medical Device_2014-04